1. Keller HJ, Keppler BK, Schmähl D: Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butane-dionato)titanium(IV) compounds against Walker carcinosarcoma. Arzneimittel-Forsch/Drug Res 32:806?807, 1982
2. Keppler BK, Heim ME: Antitumor-active bis-?-diketonato metal complexes: budotitane ? a new anticancer agent. Drugs of the Future 13:637?652, 1988
3. Keppler BK, Michels K: Antitumor activity of 1,3-diketonato zirconium (IV) and hafnium (IV) complexes. Arzneimittel-Forsch/Drug Res 35:1837?1839, 1985
4. Keppler BK, Schmähl D: Preclinical evaluation of dichlorbis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Arzneimittel-Forsch/Drug Res 36:1822?1826, 1986
5. Bischoff H, Berger MR, Keppler BK, Schmähl D: Efficacy of ?-diketonato complexes of titanium, zirconim and hafnium against chemically induced autochtonous colonic tumors in rats. J Cancer Res Clin Oncol 113: 446?450, 1987